- Home
- ANIP vs BKV Comparison
ANIP vs BKV Comparison
Compare ANIP & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- BKV
- Stock Information
- Founded
- ANIP 2001
- BKV 2015
- Country
- ANIP United States
- BKV United States
- Employees
- ANIP N/A
- BKV N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- BKV Oil & Gas Production
- Sector
- ANIP Health Care
- BKV Energy
- Exchange
- ANIP Nasdaq
- BKV Nasdaq
- Market Cap
- ANIP 2.0B
- BKV 1.8B
- IPO Year
- ANIP N/A
- BKV 2024
- Fundamental
- Price
- ANIP $90.08
- BKV $21.35
- Analyst Decision
- ANIP Strong Buy
- BKV Strong Buy
- Analyst Count
- ANIP 9
- BKV 9
- Target Price
- ANIP $82.89
- BKV $28.11
- AVG Volume (30 Days)
- ANIP 696.2K
- BKV 358.1K
- Earning Date
- ANIP 08-08-2025
- BKV 08-12-2025
- Dividend Yield
- ANIP N/A
- BKV N/A
- EPS Growth
- ANIP N/A
- BKV N/A
- EPS
- ANIP N/A
- BKV N/A
- Revenue
- ANIP $747,399,000.00
- BKV $756,795,000.00
- Revenue This Year
- ANIP $31.40
- BKV $28.56
- Revenue Next Year
- ANIP $7.38
- BKV $35.30
- P/E Ratio
- ANIP N/A
- BKV N/A
- Revenue Growth
- ANIP 38.68
- BKV 13.79
- 52 Week Low
- ANIP $52.50
- BKV $15.00
- 52 Week High
- ANIP $91.01
- BKV $26.78
- Technical
- Relative Strength Index (RSI)
- ANIP 80.26
- BKV N/A
- Support Level
- ANIP $85.44
- BKV N/A
- Resistance Level
- ANIP $68.18
- BKV N/A
- Average True Range (ATR)
- ANIP 3.40
- BKV 0.00
- MACD
- ANIP 1.96
- BKV 0.00
- Stochastic Oscillator
- ANIP 96.69
- BKV 0.00
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About BKV BKV Corporation Common Stock
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).